{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:06:52Z","timestamp":1791860812271,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300483"],"award-info":[{"award-number":["82300483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wuxi Municipal Science and Technology Bureau","award":["K20231056"],"award-info":[{"award-number":["K20231056"]}]},{"name":"Scientific Research Program of Wuxi Health Commission","award":["Q202420"],"award-info":[{"award-number":["Q202420"]}]},{"name":"Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee","award":["BJ2023086"],"award-info":[{"award-number":["BJ2023086"]}]},{"name":"Wuxi Taihu Talent Project","award":["No. WXTTP 2021"],"award-info":[{"award-number":["No. WXTTP 2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07479-8","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:10:35Z","timestamp":1761300635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cognitive dysfunction in schizophrenia: association with peripheral blood inflammatory signatures"],"prefix":"10.1186","volume":"25","author":[{"given":"Peipei","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"1\u20133","key":"7479_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","volume":"110","author":"R Tandon","year":"2009","unstructured":"Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia. Just the facts 4. Clinical features and conceptualization. Schizophr Res. 2009;110(1\u20133):1\u201323.","journal-title":"Schizophr Res"},{"issue":"7321","key":"7479_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature09552","volume":"468","author":"TR Insel","year":"2010","unstructured":"Insel TR. Rethinking schizophrenia. Nature. 2010;468(7321):187\u201393.","journal-title":"Nature"},{"key":"7479_CR3","doi-asserted-by":"crossref","unstructured":"Kadakia A, Catillon M, Fan Q, Williams GR, Marden JR, Anderson A, et al. The economic burden of schizophrenia in the United States. J Clin Psychiatry. 2022;83(6):22m14458.","DOI":"10.4088\/JCP.22m14458"},{"issue":"5","key":"7479_CR4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/schbul\/sby024","volume":"44","author":"N M\u00fcller","year":"2018","unstructured":"M\u00fcller N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull. 2018;44(5):973\u201382.","journal-title":"Schizophr Bull"},{"key":"7479_CR5","doi-asserted-by":"publisher","first-page":"110626","DOI":"10.1016\/j.pnpbp.2022.110626","volume":"120","author":"Z Fi\u0161ar","year":"2023","unstructured":"Fi\u0161ar Z. Biological hypotheses, risk factors, and biomarkers of schizophrenia. Prog Neuro-psychopharmacol Biol Psychiatry. 2023;120:110626.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"1","key":"7479_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-pharmtox-051921-093250","volume":"63","author":"DC Javitt","year":"2023","unstructured":"Javitt DC. Cognitive impairment associated with schizophrenia: from pathophysiology to treatment. Annu Rev Pharmacol Toxicol. 2023;63(1):119\u201341.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7479_CR7","doi-asserted-by":"publisher","first-page":"787383","DOI":"10.3389\/fnbeh.2021.787383","volume":"15","author":"A Mart\u00ednez","year":"2021","unstructured":"Mart\u00ednez A, Tobe RH, Gaspar PA, Malinsky D, Dias EC, Sehatpour P, et al. Disease-Specific contribution of pulvinar dysfunction to impaired emotion recognition in schizophrenia. Front Behav Neurosci. 2021;15:787383.","journal-title":"Front Behav Neurosci"},{"issue":"16","key":"7479_CR8","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1017\/S0033291720001646","volume":"51","author":"GH Patel","year":"2021","unstructured":"Patel GH, Arkin SC, Ruiz-Betancourt DR, DeBaun HM, Strauss NE, Bartel LP, et al. What you see is what you get: visual scanning failures of naturalistic social scenes in schizophrenia. Psychol Med. 2021;51(16):2923\u201332.","journal-title":"Psychol Med"},{"issue":"6","key":"7479_CR9","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1093\/brain\/awab081","volume":"144","author":"GH Patel","year":"2021","unstructured":"Patel GH, Arkin SC, Ruiz-Betancourt DR, Plaza FI, Mirza SA, Vieira DJ, et al. Failure to engage the temporoparietal junction\/posterior superior temporal sulcus predicts impaired naturalistic social cognition in schizophrenia. Brain. 2021;144(6):1898\u2013910.","journal-title":"Brain"},{"issue":"5","key":"7479_CR10","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28(5):1902\u201318.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"7479_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S2215-0366(19)30302-5","volume":"7","author":"AG Dietz","year":"2020","unstructured":"Dietz AG, Goldman SA, Nedergaard M. Glial cells in schizophrenia: a unified hypothesis. Lancet Psychiatry. 2020;7(3):272\u201381.","journal-title":"Lancet Psychiatry"},{"key":"7479_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.comppsych.2019.01.003","volume":"90","author":"Y Luo","year":"2019","unstructured":"Luo Y, He H, Zhang J, Ou Y, Fan N. Changes in serum TNF-\u03b1, IL-18, and IL-6 concentrations in patients with chronic schizophrenia at admission and at discharge. Compr Psychiatry. 2019;90:82\u20137.","journal-title":"Compr Psychiatry"},{"issue":"1","key":"7479_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00429-012-0491-5","volume":"219","author":"C Kaur","year":"2014","unstructured":"Kaur C, Sivakumar V, Zou Z, Ling EA. Microglia-derived proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta induce purkinje neuronal apoptosis via their receptors in hypoxic neonatal rat brain. Brain Struct Funct. 2014;219(1):151\u201370.","journal-title":"Brain Struct Funct"},{"issue":"5","key":"7479_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.immuni.2020.09.018","volume":"53","author":"A Shemer","year":"2020","unstructured":"Shemer A, Scheyltjens I, Frumer GR, Kim JS, Grozovski J, Ayanaw S, et al. Interleukin-10 prevents pathological microglia hyperactivation following peripheral endotoxin challenge. Immunity. 2020;53(5):1033\u2013e497.","journal-title":"Immunity"},{"issue":"3","key":"7479_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1124\/jpet.114.213074","volume":"349","author":"MA Erickson","year":"2014","unstructured":"Erickson MA, Morofuji Y, Owen JB, Banks WA. Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells. J Pharmacol Exp Ther. 2014;349(3):497\u2013507.","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"7479_CR16","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/glia.22892","volume":"63","author":"B Parajuli","year":"2015","unstructured":"Parajuli B, Horiuchi H, Mizuno T, Takeuchi H, Suzumura A. CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia. Glia. 2015;63(12):2274\u201384.","journal-title":"Glia"},{"issue":"7362","key":"7479_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477(7362):90\u20134.","journal-title":"Nature"},{"key":"7479_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032215","author":"EA Ermakov","year":"2023","unstructured":"Ermakov EA, Mednova IA, Boiko AS, Buneva VN, Ivanova SA. Chemokine dysregulation and neuroinflammation in schizophrenia: a systematic review. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032215.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7479_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.pnpbp.2007.11.019","volume":"32","author":"AL Teixeira","year":"2008","unstructured":"Teixeira AL, Reis HJ, Nicolato R, Brito-Melo G, Correa H, Teixeira MM, et al. Increased serum levels of CCL11\/eotaxin in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2008;32(3):710\u20134.","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"10","key":"7479_CR20","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jpsychires.2013.05.032","volume":"47","author":"E Asevedo","year":"2013","unstructured":"Asevedo E, Gadelha A, Noto C, Mansur RB, Zugman A, Belangero SI, et al. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia. J Psychiatr Res. 2013;47(10):1376\u201382.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"7479_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/15622975.2015.1062552","volume":"16","author":"C Noto","year":"2015","unstructured":"Noto C, Maes M, Ota VK, Teixeira AL, Bressan RA, Gadelha A, et al. High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance. World J Biol Psychiatry. 2015;16(6):422\u20139.","journal-title":"World J Biol Psychiatry"},{"key":"7479_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2016.09.019","volume":"181","author":"S Hong","year":"2017","unstructured":"Hong S, Lee EE, Martin AS, Soontornniyomkij B, Soontornniyomkij V, Achim CL, et al. Abnormalities in chemokine levels in schizophrenia and their clinical correlates. Schizophr Res. 2017;181:63\u20139.","journal-title":"Schizophr Res"},{"key":"7479_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jad.2021.03.062","volume":"287","author":"AF Almulla","year":"2021","unstructured":"Almulla AF, Al-Rawi KF, Maes M, Al-Hakeim HK. In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms. J Affect Disord. 2021;287:316\u201326.","journal-title":"J Affect Disord"},{"key":"7479_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2018.05.002","volume":"71","author":"D Frydecka","year":"2018","unstructured":"Frydecka D, Krzystek-Korpacka M, Lubeiro A, Stramecki F, Sta\u0144czykiewicz B, Besz\u0142ej JA, et al. Profiling inflammatory signatures of schizophrenia: a cross-sectional and meta-analysis study. Brain Behav Immun. 2018;71:28\u201336.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"7479_CR25","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696\u2013709.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"7479_CR26","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/schbul\/sby160","volume":"45","author":"T Pillinger","year":"2019","unstructured":"Pillinger T, Osimo EF, Brugger S, Mondelli V, McCutcheon RA, Howes OD. A meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis. Schizophr Bull. 2019;45(5):1120\u201333.","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"7479_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.schres.2012.03.004","volume":"137","author":"M Mart\u00ednez-Cengotitabengoa","year":"2012","unstructured":"Mart\u00ednez-Cengotitabengoa M, Mac-Dowell KS, Leza JC, Mic\u00f3 JA, Fernandez M, Echevarr\u00eda E, et al. Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes. Schizophr Res. 2012;137(1\u20133):66\u201372.","journal-title":"Schizophr Res"},{"key":"7479_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00025","volume":"11","author":"BM Bettcher","year":"2019","unstructured":"Bettcher BM, Neuhaus J, Wynn MJ, Elahi FM, Casaletto KB, Saloner R, et al. Increases in a pro-inflammatory chemokine, MCP-1, are related to decreases in memory over time. Front Aging Neurosci. 2019;11:25.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"7479_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/acps.12944","volume":"138","author":"F Orhan","year":"2018","unstructured":"Orhan F, Schwieler L, Fatouros-Bergman H, Malmqvist A, Cervenka S, Collste K, et al. Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis. Acta Psychiatr Scand. 2018;138(5):432\u201340.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"7479_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27\u201337.","journal-title":"Int Anesthesiol Clin"},{"issue":"11","key":"7479_CR31","doi-asserted-by":"publisher","first-page":"e1256","DOI":"10.1212\/WNL.0000000000007094","volume":"92","author":"KA Walker","year":"2019","unstructured":"Walker KA, Gottesman RF, Wu A, Knopman DS, Gross AL, Mosley TH Jr., et al. Systemic inflammation during midlife and cognitive change over 20 years: the ARIC study. Neurology. 2019;92(11):e1256-67.","journal-title":"Neurology"},{"issue":"4","key":"7479_CR32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00406-021-01237-z","volume":"271","author":"HF North","year":"2021","unstructured":"North HF, Bruggemann J, Cropley V, Swaminathan V, Sundram S, Lenroot R, et al. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatry Clin Neurosci. 2021;271(4):595\u2013607.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"8","key":"7479_CR33","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/mp.2015.90","volume":"21","author":"SG Fillman","year":"2016","unstructured":"Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS, et al. Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca\u2019s area volume. Mol Psychiatry. 2016;21(8):1090\u20138.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"7479_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2013.05.028","volume":"150","author":"R Tandon","year":"2013","unstructured":"Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res. 2013;150(1):3\u201310.","journal-title":"Schizophr Res"},{"key":"7479_CR35","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders (5th ed.). American\u00a0Psychiatr\u00a0Publishing;2013."},{"issue":"2","key":"7479_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261\u201376.","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"7479_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.schres.2015.09.003","volume":"169","author":"C Shi","year":"2015","unstructured":"Shi C, Kang L, Yao S, Ma Y, Li T, Liang Y, et al. The MATRICS consensus cognitive battery (MCCB): co-norming and standardization in China. Schizophr Res. 2015;169(1\u20133):109\u201315.","journal-title":"Schizophr Res"},{"issue":"2","key":"7479_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1176\/appi.ajp.2007.07010043","volume":"165","author":"RS Kern","year":"2008","unstructured":"Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, et al. The MATRICS consensus cognitive battery, part 2: co-norming and standardization. Am J Psychiatry. 2008;165(2):214\u201320.","journal-title":"Am J Psychiatry"},{"key":"7479_CR39","unstructured":"Angeloni SDS, Dunbar S, Stone V, Swift S. xMap Cookbook: A Colection of methods and protocols for developing multiplex assays with xMAP Technology. [Available from: https:\/\/info.diasorin.com\/en-us\/research\/download-the-xmap-cookbook."},{"issue":"7","key":"7479_CR40","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aab4b1","volume":"63","author":"NA Obuchowski","year":"2018","unstructured":"Obuchowski NA, Bullen JA. Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine. Phys Med Biol. 2018;63(7):07tr1.","journal-title":"Phys Med Biol"},{"key":"7479_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpsychires.2018.08.017","volume":"105","author":"B Stapel","year":"2018","unstructured":"Stapel B, Sieve I, Falk CS, Bleich S, Hilfiker-Kleiner D, Kahl KG. Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells. J Psychiatr Res. 2018;105:95\u2013102.","journal-title":"J Psychiatr Res"},{"key":"7479_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ph13090230","author":"M Ivanovska","year":"2020","unstructured":"Ivanovska M, Abdi Z, Murdjeva M, Macedo D, Maes A, Maes M. CCL-11 or Eotaxin-1: an immune marker for ageing and accelerated ageing in neuro-psychiatric disorders. Pharmaceuticals. 2020. https:\/\/doi.org\/10.3390\/ph13090230.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"7479_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1241-2","volume":"15","author":"K Zhang","year":"2018","unstructured":"Zhang K, Wang H, Xu M, Frank JA, Luo J. Role of MCP-1 and CCR2 in ethanol-induced neuroinflammation and neurodegeneration in the developing brain. J Neuroinflammation. 2018;15(1):197.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"7479_CR44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/schbul\/sbx015","volume":"44","author":"LS Czepielewski","year":"2018","unstructured":"Czepielewski LS, Massuda R, Panizzutti B, Grun LK, Barb\u00e9-Tuana FM, Teixeira AL, et al. Telomere length and CCL11 levels are associated with Gray matter volume and episodic memory performance in schizophrenia: evidence of pathological accelerated aging. Schizophr Bull. 2018;44(1):158\u201367.","journal-title":"Schizophr Bull"},{"issue":"2","key":"7479_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/1871527317666181119115532","volume":"18","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M. A new schizophrenia model: immune activation is associated with the induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom Dimensions. CNS Neurol Disord Drug Targets. 2019;18(2):124\u201340.","journal-title":"CNS Neurol Disord Drug Targets."},{"issue":"3","key":"7479_CR46","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12640-019-00112-z","volume":"37","author":"HK Al-Hakeim","year":"2020","unstructured":"Al-Hakeim HK, Almulla AF, Maes M. The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study. Neurotox Res. 2020;37(3):753\u201371.","journal-title":"Neurotox Res"},{"issue":"3","key":"7479_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","volume":"18","author":"NM Simon","year":"2008","unstructured":"Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, et al. A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol. 2008;18(3):230\u20133.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"7479_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jpsychires.2013.10.007","volume":"48","author":"PV Magalhaes","year":"2014","unstructured":"Magalhaes PV, Jansen K, Stertz L, Ferrari P, Pinheiro RT, da Silva RA, et al. Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults. J Psychiatr Res. 2014;48(1):13\u20135.","journal-title":"J Psychiatr Res"},{"issue":"10","key":"7479_CR49","doi-asserted-by":"publisher","first-page":"7964","DOI":"10.1007\/s12035-016-0269-5","volume":"54","author":"C Zhu","year":"2017","unstructured":"Zhu C, Xu B, Sun X, Zhu Q, Sui Y. Targeting CCR3 to reduce Amyloid-\u03b2 production, tau hyperphosphorylation, and synaptic loss in a mouse model of alzheimer\u2019s disease. Mol Neurobiol. 2017;54(10):7964\u201378.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"7479_CR50","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/mp.2015.131","volume":"20","author":"MA Lalli","year":"2015","unstructured":"Lalli MA, Bettcher BM, Arcila ML, Garcia G, Guzman C, Madrigal L, et al. Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in Familial Alzheimer\u2019s disease. Mol Psychiatry. 2015;20(11):1294\u2013300.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"7479_CR51","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/mp.2014.59","volume":"20","author":"A Masi","year":"2015","unstructured":"Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry. 2015;20(4):440\u20136.","journal-title":"Mol Psychiatry"},{"key":"7479_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01026","volume":"13","author":"Z Bai","year":"2019","unstructured":"Bai Z, Chen D, Wang L, Zhao Y, Liu T, Yu Y, et al. Cerebrospinal fluid and blood cytokines as biomarkers for multiple sclerosis: a systematic review and meta-analysis of 226 studies with 13,526 multiple sclerosis patients. Front Neurosci. 2019;13:1026.","journal-title":"Front Neurosci"},{"key":"7479_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","volume":"33","author":"D Lindqvist","year":"2013","unstructured":"Lindqvist D, Hall S, Surova Y, Nielsen HM, Janelidze S, Brundin L, et al. Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease\u2013associations with depression, fatigue, and cognitive impairment. Brain Behav Immun. 2013;33:183\u20139.","journal-title":"Brain Behav Immun"},{"issue":"6","key":"7479_CR54","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s12975-017-0545-3","volume":"8","author":"M Roy-O\u2019Reilly","year":"2017","unstructured":"Roy-O\u2019Reilly M, Ritzel RM, Conway SE, Staff I, Fortunato G, McCullough LD. CCL11 (eotaxin-1) levels predict long-term functional outcomes in patients following ischemic stroke. Transl Stroke Res. 2017;8(6):578\u201384.","journal-title":"Transl Stroke Res"},{"key":"7479_CR55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpsychires.2021.04.007","volume":"138","author":"F Klaus","year":"2021","unstructured":"Klaus F, Mitchell K, Liou SC, Eyler LT, Nguyen TT. Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: a preliminary analysis. J Psychiatr Res. 2021;138:139\u201345.","journal-title":"J Psychiatr Res"},{"issue":"12","key":"7479_CR56","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","volume":"37","author":"W Beumer","year":"2012","unstructured":"Beumer W, Drexhage RC, De Wit H, Versnel MA, Drexhage HA, Cohen D. Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology. 2012;37(12):1901\u201311.","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"7479_CR57","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","volume":"15","author":"AR Morgan","year":"2019","unstructured":"Morgan AR, Touchard S, Leckey C, O\u2019Hagan C, Nevado-Holgado AJ, Barkhof F, et al. Inflammatory biomarkers in alzheimer\u2019s disease plasma. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2019;15(6):776\u201387.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"issue":"12","key":"7479_CR58","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.neurobiolaging.2005.10.007","volume":"27","author":"D Galimberti","year":"2006","unstructured":"Galimberti D, Fenoglio C, Lovati C, Venturelli E, Guidi I, Corr\u00e0 B, et al. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer\u2019s disease. Neurobiol Aging. 2006;27(12):1763\u20138.","journal-title":"Neurobiol Aging"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07479-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07479-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07479-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:03:55Z","timestamp":1761303835000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07479-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7479"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07479-8","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent, and the study was approved by the Ethics Committee of the Wuxi Mental Health Center (WXMHCIRB2022LLky002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1020"}}